Source: Annual Congress 2001 - COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Nishimura, S. Sato, T. Oga, M. Tsukino (Kyoto, Japan). Acute exacerbation is not related to the decline of airway calibre in patients with COPD. Eur Respir J 2001; 16: Suppl. 31, 1322

Member's Comments

No comment yet.

Related content which might interest you: Changes in FEV1 after recovery from COPD exacerbation are driven by heterogeneous regional changes in airway caliber and hyperinflation Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015 Pulmonary volumes change more largely than respiratory flows in COPD patients during severe acute exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005 A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Improvement in FEV1 after acute COPD exacerbations are driven more by changes in hyperinflation than changes in proximal airway volume Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease Year: 2015 Bronchial colonization and inflammatory response in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation Source: Eur Respir J 2001; 18: Suppl. 33, 540s Year: 2001 Predictors of exercise-induced airways obstruction in patients with mild asthma. Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases Year: 2020 Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 Relationship between the severity of dyspnea and pulmonary function in acute COPD exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 251s Year: 2002 Airways obstruction is associated with increased cardiac injury and systemic inflammation in patients with stable COPD Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 Airway resistance correlates with the frequency of exacerbation in patient with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Bronchodilator-induced changes in dynamic hyperinflation but not in airway obstruction are associated with improvement in dyspnoea in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 174s Year: 2001 Association between arterial stiffness and acute exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Endocrinopathies and related with COPD exacerbation Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Severe exacerbations predict excess lung function decline in asthma Source: Eur Respir J 2007; 30: 452-456 Year: 2007 Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Acute COPD exacerbations cause alteration of the endothelium-coagulative system Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003 Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016